Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 NeoGenomics Opens New Lab in Singapore | Contract Pharma

What are you searching for?

Sign in
Breaking News

NeoGenomics Opens New Lab in Singapore

Oncology-focused testing lab will support Asia-Pacific oncology-based clinical trials

By: Cassandra Gervolino

NeoGenomics, Inc. opened a NeoGenomics oncology-focused clinical trials testing lab in the same building as the PPD Laboratories central lab in Singapore. 
 
NeoGenomics Chairman and Chief Executive Officer, Doug VanOort noted, “Our customers in the Pharmaceutical Services Division are truly global customers who want the ability to place studies wherever they can find the enrollees. They are looking to partner with laboratories that provide great service and high quality, consistent testing across the globe. We’re very excited about our Singapore laboratory and the potential growth opportunity we see within the Asia-Pacific region. This is another milestone in our plan to be a premier global provider of services to the pharmaceutical industry.”
  
“This expansion of our collaboration with NeoGenomics in Singapore is a critical step in enhancing our pathology and molecular capabilities in the Asia-Pacific region, one of the fastest-growing areas of the world for clinical trials,” said Christopher Fikry, M.D., executive vice president of PPD Laboratories. “Our pharmaceutical and biotech customers who are increasing their clinical trial investments in Asia can depend on us to provide one of the industry’s most comprehensive sets of labs services where they have the greatest need. We look forward to further strengthening our alliance with NeoGenomics and jointly supporting global and regional oncology trials.”
 
Douglas VanOort added, “Our mutual clients are excited about NeoGenomics having the capability to handle testing for their study enrollees across the globe. We are thrilled to expand our collaboration with PPD by providing clients with even greater access to our leading scientific and clinical professionals, as well as best-in-class oncology testing.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics